Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.27B
-
Number of holders
-
39
-
Total 13F shares, excl. options
-
6.6M
-
Shares change
-
+2.09M
-
Total reported value, excl. options
-
$521M
-
Value change
-
+$165M
-
Number of buys
-
17
-
Number of sells
-
-11
-
Price
-
$78.96
Significant Holders of CVS HEALTH Corp - Common Stock (CVS) as of Q4 2023
39 filings reported holding CVS - CVS HEALTH Corp - Common Stock as of Q4 2023.
CVS HEALTH Corp - Common Stock (CVS) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.6M shares
of 1.27B outstanding shares and own 0.52% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (118M shares), BlackRock Inc. (87M shares), STATE STREET CORP (55.2M shares), Capital World Investors (40.5M shares), FMR LLC (37.8M shares), Capital International Investors (33.7M shares), MORGAN STANLEY (30.6M shares), Dodge & Cox (30.4M shares), GEODE CAPITAL MANAGEMENT, LLC (24.5M shares), and Invesco Ltd. (16M shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.